Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

HKG/3347 stock hub

HKG/3347 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/3347is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

47.8B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/3347

In the news

Latest news · HKG/3347

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E34

P25 11.7P50 18.9P75 41.4

Trailing P/E54.5

P25 10.7P50 17.9P75 38.5

ROE4.2

P25 -14.7P50 2P75 9.4

ROIC2.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/3347 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

CNY

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	11,130
Employees Change	945%
Employees Change Percent	9.28
Enterprise value	HKD 51.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	CNE1000040M1
Last refreshed	2026-05-10
Market cap	HKD 47.8B
Price	HKD 38.18
Price currency	HKD
Rev Per Employee	722,047.41x
Sector	Healthcare
Sic	8731
Symbol	hkg/3347
Website	https://www.tigermedgrp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.83%
EV Earnings	58.68x
EV/EBIT	73.21x
EV/EBITDA	47.61x
EV/FCF	44.34x
EV/Sales	6.32x
FCF yield	2.43%
Forward P/E	33.96x
P/B ratio	1.71x
P/E ratio	54.52x
P/S ratio	5.95x
PE Ratio10 Y	61.81x
PE Ratio3 Y	62.56x
PE Ratio5 Y	55.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.64%
EBITDA Margin	11.66%
FCF margin	14.44%
Gross margin	26.64%
Gross Profit	HKD 2.1B
Gross Profit Growth	-9.71%
Gross Profit Growth Q	2.16%
Gross Profit Growth3 Y	-12.57%
Gross Profit Growth5 Y	2.85%
Net Income	HKD 876.9M
Net Income Growth	129.92%
Net Income Growth Q	-70.36%
Net Income Growth Years	1%
Net Income Growth3 Y	-27.88%
Net Income Growth5 Y	-16.93%
Pretax Margin	17.9%
Profit Margin	10.91%
Profit Per Employee	HKD 78,787
Profitable Years	17
ROA	1.33
Roa5y	3.08
ROCE	2.36
ROE	4.23
Roe5y	8.49
ROIC	2.05
Roic5y	6.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	43.38%
Cagr3y	-15.52%
Cagr5y	-22.42%
Div CAGR3	-17.58%
EPS Growth	135.5
EPS Growth Q	-68.42
EPS Growth Years	1
EPS Growth3 Y	-27.27
EPS Growth5 Y	-17.17
FCF Growth	19.07%
FCF Growth Q	78.37%
FCF Growth3 Y	18.53%
FCF Growth5 Y	2.66%
OCF Growth	7.57%
OCF Growth Q	60.51%
OCF Growth10 Y	24.78%
OCF Growth3 Y	4.56%
OCF Growth5 Y	1.52%
Revenue Growth	8.65x
Revenue Growth Q	15.17x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.01x
Revenue Growth5 Y	15.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.25
Assets	HKD 32.7B
Cash	HKD 2.5B
Current Assets	HKD 7.6B
Current Liabilities	HKD 3.3B
Debt	HKD 2B
Debt EBITDA	HKD 1.83
Debt Equity	HKD 0.07
Debt FCF	HKD 1.69
Equity	HKD 27.9B
Interest Coverage	7.54
Liabilities	HKD 4.8B
Long Term Assets	HKD 25.1B
Long Term Liabilities	HKD 1.5B
Net Cash	HKD 545.1M
Net Cash By Market Cap	HKD 1.14
Net Debt EBITDA	HKD -0.58
Net Debt Equity	HKD -0.02
Net Debt FCF	HKD -0.47
Tangible Book Value	HKD 19.5B
Tangible Book Value Per Share	HKD 22.83
WACC	7.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.3
Inventory Turnover	112.3
Net Working Capital	HKD 2.4B
Quick ratio	2.22
Working Capital	HKD 4.3B
Working Capital Turnover	HKD 2.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.39%
Dividend Growth	-47.97%
Dividend Growth Years	0%
Dividend per share	HKD 0.32
Dividend Years	5
Dividend Yield	0.85%
Ex Div Date	2025-06-12
Last Dividend	HKD 0.32
Payout Frequency	Annual
Payout Ratio	42.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	43.35%
200-day SMA	45.98
3Y total return	-39.71%
50-day SMA	42.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.9%
All Time High	199.9
All Time High Change	-80.9%
All Time High Date	2021-01-06
All Time Low	22.1
All Time Low Change	72.76%
All Time Low Date	2024-02-14
ATR	2.03
Beta	0.62
Ch YTD	-10.25
High	39.6
High52	60.6
High52 Date	2025-07-30
High52ch	-37%
Low	37.72
Low52	24.55
Low52 Date	2025-05-19
Low52ch	55.52%
Ma50ch	-9.67%
Price vs 200-day SMA	-16.96%
RSI	37.82
RSI Monthly	46.25
RSI Weekly	41.16
Sharpe ratio	0.9x
Sortino ratio	1.55
Total Return	3.24%
Tr YTD	-10.25
Tr1m	-10.59%
Tr1w	-4.5%
Tr3m	-29.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 694.1M
Operating Income Growth	-28
Operating Income Growth Q	1.22
Operating Income Growth3 Y	-29.34
Operating Income Growth5 Y	-8.52
Operating margin	8.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	616,872,831%
Net Borrowing	-1,764,970,902.6
Shares Insiders	27.86%
Shares Institutions	33.67%
Shares Qo Q	-3.95%
Shares Yo Y	-2.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.2B
Average Volume	1,855,141.45x
Bv Per Share	27.8
CAPEX	HKD -246.3M
Ch1m	-10.59
Ch1w	-4.5
Ch1y	42.2
Ch3m	-29.3
Ch3y	-41.89
Ch5y	-73.17
Ch6m	-10.29
Change	-3.44%
Change From Open	-3.59
Close	39.54
Days Gap	0.15
Depreciation Amortization	245,846,067.3
Dollar Volume	48,626,849.8
Earnings Date	2026-04-29
EBIT	HKD 694.1M
EBITDA	HKD 936.7M
EPS	HKD 1.04
F Score	6
FCF	HKD 1.2B
FCF EV Yield	2.26x
Financing CF	-2,063,329,015
Fiscal Year End	December
Founded	2,004
Goodwill	4,013,024,335
Graham Number	18.74283
Graham Upside	-50.91
Income Tax	HKD 273.2M
Investing CF	1,368,163,456
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	HKD 3.5
Lynch Upside	-90.83
Ma150	44.22
Ma150ch	-13.67%
Ma20	41.73
Ma20ch	-8.51%
Net CF	679,745,140
Next Earnings Date	2026-08-25
Open	39.6
P FCF Ratio	41.19
P OCF Ratio	33.98
Payment Date	2025-07-11
Position In Range	24.47
Ppne	1,935,447,389.3
Price Date	2026-05-08
Price EBITDA	HKD 51.04
Ptbv Ratio	2.45
Relative Volume	0.67x
Revenue	8,036,387,630x
Tax By Revenue	3.4x
Tax Rate	18.99%
Tr6m	-10.29%
Volume	1,273,621
Z Score	7.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/3347 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.32 annual per share

Payout ratio

+43.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2025-06-12

Performance

HKG/3347 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/3347?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.7%

Share of float held by funds and institutions

Insider ownership

+27.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.4%

Negative means the company is buying back shares.

Technical

HKG/3347 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.8

Neutral momentum band

Price vs 200-day MA

-17.0%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/3347

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/3347 stock rating?

hkg/3347 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/3347 analysis?

The full report lives at /stocks/hkg/3347/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/3347?

The latest report frames hkg/3347 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/3347 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.